Glycologix

About:

Glycologix is a biotechnology company that specializes in R&D of biomaterials for the protection and repair of soft tissues.

Website: http://www.glycologix.com/

Top Investors: Cortado Ventures

Description:

Glycologix is a biotechnology company that focuses on locally delivered biopolymers for soft tissue protection. Replenishing naturally occurring proteoglycans can help with a variety of unmet medical conditions. Its platform discovery engine makes it possible to create synthetic structural mimics of proteoglycans. These novel materials are highly soluble despite their high molecular weight, allowing for optimal tissue coverage. Interstitial cystitis, dry eye, post-surgical adhesion prevention, osteoarthritis, spinal disk disease, and wound repair are among the platform's targeted indications.

Total Funding Amount:

$4.4M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Beverly, Massachusetts, United States

Founded Date:

2016-01-01

Contact Email:

info(AT)glycologix.com

Founders:

Thomas H. Jozefiak

Number of Employees:

1-10

Last Funding Date:

2024-04-05

IPO Status:

Private

Industries:

© 2025 bioDAO.ai